Search Results - "WILDER, Richard B"

Cross-Linked Hyaluronan Gel Reduces the Acute Rectal Toxicity of Radiotherapy for Prostate Cancer by Wilder, Richard B., M.D, Barme, Greg A., M.D, Gilbert, Ronald F., M.D, Holevas, Richard E., M.D, Kobashi, Luis I., M.D, Reed, Richard R., M.D, Solomon, Ronald S., M.D, Walter, Nancy L., R.N, Chittenden, Lucy, B.S, Mesa, Albert V., M.S, Agustin, Jeffrey, B.S, Lizarde, Jessica, B.S, Macedo, Jorge, Ravera, John, M.D, Tokita, Kenneth M., M.D

“…Purpose To prospectively analyze whether cross-linked hyaluronan gel reduces the mean rectal dose and acute rectal toxicity of radiotherapy for prostate…”
Get full text

Radiotherapy Treatment Planning for Testicular Seminoma by Wilder, Richard B., M.D., M.S., M.B.A, Buyyounouski, Mark K., M.D., M.S, Efstathiou, Jason A., M.D., D.Phil, Beard, Clair J., M.D

“…Virtually all patients with Stage I testicular seminoma are cured regardless of postorchiectomy management. For patients treated with adjuvant radiotherapy,…”
Get full text

A Prospective Study of Intrafraction Prostate Motion in the Prone vs. Supine Position by Wilder, Richard B., M.D, Chittenden, Lucy, B.S, Mesa, Albert V., M.S, Bunyapanasarn, Jane, B.S, Agustin, Jeff, B.S, Lizarde, Jessica, B.S, Ravera, John, M.D, Tokita, Kenneth M., M.D

“…Purpose To prospectively analyze prostate intrafraction motion in the prone vs. supine position and to assess patient satisfaction with these two positions…”
Get full text

Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy by Chronowski, Gregory M., Ha, Chul S., Wilder, Richard B., Cabanillas, Fernando, Manning, John, Cox, James D.

“…BACKGROUND Although surgery is considered standard therapy for unicentric Castleman disease, favorable responses to radiotherapy also have been documented. The…”
Get full text

Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses by Abuodeh, Yazan A, Naghavi, Arash O, Juan, Tzu-Hua, Ma, Zhenjun, Wilder, Richard B

“…To evaluate quality of life (QoL) after post-prostatectomy intensity modulated radiation therapy (IMRT) in the "adjuvant" setting starting within 4 months of…”
Get full text

Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer by Naghavi, Arash O., Strom, Tobin J., Nethers, Kevin, Cruz, Alex A., Figura, Nicholas B., Shrinath, Kushagra, Yue, Binglin, Kim, Jongphil, Biagioli, Matthew C., Fernandez, Daniel C., Heysek, Randy V., Wilder, Richard B.

“…Background The objectives are to determine predictors of a prostate-specific antigen (PSA) bounce, whether a PSA bounce after radiotherapy for prostate cancer…”
Get full text

Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone by Wilder, Richard B., Ha, Chul S., Cox, James D., Weber, Donna, Delasalle, Kay, Alexanian, Raymond

“…BACKGROUND Prognostic factors for solitary plasmacytoma of bone (SPB), whether measured before or after radiotherapy (RT), have not been established. The…”
Get full text

Lipiodol as a fiducial marker for image-guided radiation therapy for bladder cancer by Freilich, Jessica M, Spiess, Philippe E, Biagioli, Matthew C, Fernandez, Daniel C C, Shi, Ellen J, Hunt, Dylan C, Gupta, Shilpa, Wilder, Richard B

“…To evaluate Lipiodol as a liquid, radio-opaque fiducial marker for image-guided radiation therapy (IGRT) for bladder cancer. Between 2011 and 2012, 5 clinical…”
Get full text

Results With Accelerated Partial Breast Irradiation in Terms of Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor 2 Status by Wilder, Richard B., M.D, Curcio, Lisa D., M.D, Khanijou, Rajesh K., M.D, Eisner, Martin E., M.D, Kakkis, Jane L., M.D, Chittenden, Lucy, B.S, Agustin, Jeffrey, B.S, Lizarde, Jessica, B.S, Mesa, Albert V., M.S, Macedo, Jorge C, Ravera, John, M.D, Tokita, Kenneth M., M.D

“…Purpose To report our results with accelerated partial breast irradiation (APBI) in terms of estrogen receptor (ER), progesterone receptor (PR), and human…”
Get full text

Dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with high-dose-rate brachytherapy for large prostate volumes by Yang, George, Strom, Tobin J, Wilder, Richard B, Shrinath, Kushagra, Mellon, Eric A, Fernandez, Daniel C, Biagioli, Matthew C

“…To evaluate dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with HDR brachytherapy for large prostate volumes. One hundred and…”
Get full text

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer by Contreras, Jessika A, Wilder, Richard B, Mellon, Eric A, Strom, Tobin J, Fernandez, Daniel C, Biagioli, Matthew C

“…There is little information in the literature on health-related quality of life (HRQOL) changes due to high-dose-rate (HDR) brachytherapy monotherapy for…”
Get full text

External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer by Strom, Tobin J, Hutchinson, Sean Z, Shrinath, Kushagra, Cruz, Alex A, Figura, Nicholas B, Nethers, Kevin, Biagioli, Matthew C, Fernandez, Daniel C, Heysek, Randy V, Wilder, Richard B

“…To assess outcomes with external beam radiation therapy (EBRT) and a low-dose-rate (LDR) brachytherapy boost without or with androgen deprivation therapy (ADT)…”
Get full text

Localized non‐Hodgkin lymphoma involving the thyroid gland by Ha, Chul S., Shadle, Kathleen M., Medeiros, L. Jeffrey, Wilder, Richard B., Hess, Mark A., Cabanillas, Fernando, Cox, James D.

“…BACKGROUND The current study was undertaken to define the natural history and patterns of failure of localized non‐Hodgkin lymphoma (NHL) involving the thyroid…”
Get full text

ACR Appropriateness Criteria® : Follow-Up of Hodgkin's Lymphoma by Ng, Andrea, MD, Constine, Louis S., MD, Advani, Ranjan, MD, Das, Prajnan, MD, MPH, Flowers, Christopher, MD, MS, Friedberg, Jonathan, MD, Hodgson, David C., MD, Schwartz, Cindy L., MD, Wilder, Richard B., MD, Wilson, Lynn D., MD, MPH, Yunes, Michael J., MD

“…In the follow-up of Hodgkin's lymphoma patients, the focus in the first 5 years is to detect recurrence, while after 5 years, the focus is on limiting and…”
Get full text

Impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans by Kubo, H D, Wilder, R B, Pappas, C T

“…The authors undertook a study to analyze the impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans. Twelve…”
Get more information

Testicular Cancer, Version 2.2015 by Motzer, Robert J, Jonasch, Eric, Agarwal, Neeraj, Beard, Clair, Bhayani, Sam, Bolger, Graeme B, Chang, Sam S, Choueiri, Toni K, Costello, Brian A, Derweesh, Ithaar H, Gupta, Shilpa, Hancock, Steven L, Kim, Jenny J, Kuzel, Timothy M, Lam, Elaine T, Lau, Clayton, Levine, Ellis G, Lin, Daniel W, Michaelson, M Dror, Olencki, Thomas, Pili, Roberto, Plimack, Elizabeth R, Rampersaud, Edward N, Redman, Bruce G, Ryan, Charles J, Sheinfeld, Joel, Shuch, Brian, Sircar, Kanishka, Somer, Brad, Wilder, Richard B, Dwyer, Mary, Kumar, Rashmi

“…Germ cell tumors (GCTs) account for 95% of testicular cancers. Testicular GCTs constitute the most common solid tumor in men between the ages of 20 and 34…”
Get more information

International prognostic index‐based outcomes for diffuse large B‐cell lymphomas by Wilder, Richard B., Rodriguez, Maria A., Medeiros, L. Jeffrey, Tucker, Susan L., Ha, Chul S., Romaguera, Jorge E., Pro, Barbara, Hess, Mark A., Cabanillas, Fernando, Cox, James D.

“…BACKGROUND We present the results of doxorubicin‐based chemotherapy with or without involved‐field radiotherapy for patients with diffuse large B‐cell lymphoma…”
Get full text

Altered Fractionation Schedules in Radiation Treatment: A Review by Ahmed, Kamran A, Correa, Candace R, Dilling, Thomas J, Rao, Nikhil G, Shridhar, Ravi, Trotti, Andy M, Wilder, Richard B, Caudell, Jimmy J

“…Conventionally fractionated radiotherapy is delivered in 1.8- to 2.0-Gy fractions. With increases in understanding of radiation and tumor biology, various…”
Get full text

A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy ± intensity modulated radiation therapy by Strom, Tobin J, Wilder, Richard B, Fernandez, Daniel C, Mellon, Eric A, Saini, Amarjit S, Hunt, Dylan C, Pow-Sang, Julio M, Spiess, Phillipe E, Sexton, Wade J, Poch, Michael A, Biagioli, Matthew C

“…Abstract Background and purpose We sought to analyze the effect of polyethylene glycol (PEG) hydrogel on rectal doses in prostate cancer patients undergoing…”
Get full text

Intravesical Lipiodol Injection Technique for Image-guided Radiation Therapy for Bladder Cancer by Baumgarten, Adam S, Emtage, Justin B, Wilder, Richard B, Biagioli, Matthew C, Gupta, Shilpa, Spiess, Philippe E

“…Introduction To describe the technique of injecting Lipiodol in the submucosa of the urinary bladder wall as a novel modality to improve localization of…”
Get full text